This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EMUC 2020
EMUC 2020
GU Malignancies Prostate
GU Malignancies Non-Prostate
EMUC 2020 GU Malignancies Prostate
Viewing 1-16 of 16 articles
EMUC 2020: Regional Treatment of Metastasis: What For?
EMUC 2020: Oligometastatic Disease in Genitourinary Cancers: Definition and Biology
EMUC 2020: Oligometastatic Disease in Genitourinary Cancers: How Reliable is Imaging?
EMUC 2020: The Rising Star: PET CT Beyond PSMA - What You Might Not Know About Different & Upcoming Tracers
EMUC 2020: Nanoparticles in Prostate Cancer: A Perspective for the Future
EMUC 2020: Ultrasound Is Improving: 29 Mhz, mpUS, C-TRUS, Elastography and Microbubbles
EMUC 2020: Active Surveillance in Intermediate Risk Prostate Cancer
EMUC 2020: The Need for Confirmatory Biopsies in Patients on Active Surveillance Who Underwent Upfront MRI with Possible Targeted Biopsy
EMUC 2020: The Predictive Value of a Pre-Operative Negative PSMA PET/CT for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection
EMUC 2020: Multiparametric MRI Changed the World of Prostate Cancer Diagnostic: Conventional MRI, Spectroscopy, mpMRI, Diffusion Weighted Imaging
EMUC 2020: Findings from the EUPROMS Survey, Patient Reported Outcomes Study
EMUC 2020: A New Treatment Paradigm for Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and BRCA1, BRCA2 or ATM Mutations, The PROfound Study
EMUC 2020: ESUP Lecture: Highlights from the Genitourinary Pathology Society (GUPS)
EMUC 2020: Who Is the Optimal Candidate for Treatment of the Primary Tumor in Oligometastic Disease?
EMUC 2020: PSMA PET for Upfront Staging in High-Risk Prostate Cancer
EMUC 2020: Germline and Mutation Testing: When and How?
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free